Skip to main content
NASDAQ:OYST

Oyster Point Pharma News Headlines

$16.38
+0.13 (+0.80 %)
(As of 05/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$16.10
$16.80
50-Day Range
$16.25
$21.91
52-Week Range
$15.86
$33.60
Volume82,077 shs
Average Volume78,687 shs
Market Capitalization$425.52 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.38

Headlines

Oyster Point Pharma (NASDAQ OYST) News Headlines Today

SourceHeadline
Oyster Point Pharma (NASDAQ:OYST) Announces Quarterly  Earnings Results, Beats Expectations By $0.18 EPSOyster Point Pharma (NASDAQ:OYST) Announces Quarterly Earnings Results, Beats Expectations By $0.18 EPS
americanbankingnews.com - May 9 at 2:48 PM
Oyster Point Pharma Reports First Quarter 2021 Financial Results and Recent Business HighlightsOyster Point Pharma Reports First Quarter 2021 Financial Results and Recent Business Highlights
finance.yahoo.com - May 6 at 7:16 PM
Oyster Point Pharma (OYST) Scheduled to Post Quarterly Earnings on ThursdayOyster Point Pharma (OYST) Scheduled to Post Quarterly Earnings on Thursday
americanbankingnews.com - May 1 at 8:24 AM
Oyster Point Pharma to Report First Quarter 2021 Financial Results on May 6, 2021Oyster Point Pharma to Report First Quarter 2021 Financial Results on May 6, 2021
finance.yahoo.com - April 30 at 10:42 AM
Oyster Point Pharma (NASDAQ:OYST) Trading Up 4.9%Oyster Point Pharma (NASDAQ:OYST) Trading Up 4.9%
americanbankingnews.com - April 27 at 2:40 PM
Equities Analysts Issue Forecasts for Oyster Point Pharma, Inc.s FY2025 Earnings (NASDAQ:OYST)Equities Analysts Issue Forecasts for Oyster Point Pharma, Inc.'s FY2025 Earnings (NASDAQ:OYST)
americanbankingnews.com - April 26 at 3:14 AM
Oyster Point Pharma (NASDAQ:OYST) Shares Gap Down to $19.90Oyster Point Pharma (NASDAQ:OYST) Shares Gap Down to $19.90
americanbankingnews.com - April 22 at 11:36 AM
Are Insiders Buying Oyster Point Pharma, Inc. (NASDAQ:OYST) Stock?Are Insiders Buying Oyster Point Pharma, Inc. (NASDAQ:OYST) Stock?
finance.yahoo.com - April 5 at 6:08 PM
FDA Accepts Oyster Points Varenicline Nasal Spray Application For Review In Dry Eye DiseaseFDA Accepts Oyster Point's Varenicline Nasal Spray Application For Review In Dry Eye Disease
markets.businessinsider.com - March 2 at 12:54 PM
Oyster Point Pharma Announces FDA Acceptance for Filing New Drug Application for OC-01 (varenicline) Nasal Spray for the Treatment of Signs and Symptoms of Dry Eye DiseaseOyster Point Pharma Announces FDA Acceptance for Filing New Drug Application for OC-01 (varenicline) Nasal Spray for the Treatment of Signs and Symptoms of Dry Eye Disease
finance.yahoo.com - March 2 at 7:53 AM
Oyster Point Pharma to Participate in the 41st Annual Cowen Healthcare ConferenceOyster Point Pharma to Participate in the 41st Annual Cowen Healthcare Conference
finance.yahoo.com - February 25 at 5:51 PM
Oyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q4 2020 Results - Earnings Call TranscriptOyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - February 20 at 1:09 AM
Oyster Point Pharma, Inc. 2020 Q4 - Results - Earnings Call PresentationOyster Point Pharma, Inc. 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 19 at 8:24 AM
Oyster Point Pharma, Inc. (OYST) Q4 2020 Earnings Call TranscriptOyster Point Pharma, Inc. (OYST) Q4 2020 Earnings Call Transcript
fool.com - February 18 at 10:50 PM
Oyster Point Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business HighlightsOyster Point Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
finance.yahoo.com - February 18 at 6:09 PM
Oyster Point Pharma to Report Fourth Quarter and Full Year 2020 Financial Results on February 18, 2021Oyster Point Pharma to Report Fourth Quarter and Full Year 2020 Financial Results on February 18, 2021
finance.yahoo.com - February 12 at 10:48 AM
Oyster Point Pharma to Participate in the 39th Annual J.P. Morgan Healthcare ConferenceOyster Point Pharma to Participate in the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 29 at 7:07 PM
Oyster Point Pharma Submits New Drug Application to the U.S. Food and Drug Administration for OC-01 (varenicline) Nasal Spray for the Treatment of Signs and Symptoms of Dry Eye DiseaseOyster Point Pharma Submits New Drug Application to the U.S. Food and Drug Administration for OC-01 (varenicline) Nasal Spray for the Treatment of Signs and Symptoms of Dry Eye Disease
finance.yahoo.com - December 18 at 8:28 AM
Is OYST A Good Stock To Buy Now?Is OYST A Good Stock To Buy Now?
finance.yahoo.com - December 13 at 1:13 AM
Oyster Point Pharma Strengthens Executive Leadership Team with the Appointment of Chief Medical and Chief Scientific OfficersOyster Point Pharma Strengthens Executive Leadership Team with the Appointment of Chief Medical and Chief Scientific Officers
finance.yahoo.com - December 7 at 9:05 AM
Oyster Point Pharma Submits a Phase 2 Clinical Trial Protocol to Evaluate OC-01 Nasal Spray for Neurotrophic Keratitis (NK)Oyster Point Pharma Submits a Phase 2 Clinical Trial Protocol to Evaluate OC-01 Nasal Spray for Neurotrophic Keratitis (NK)
finance.yahoo.com - December 1 at 6:47 PM
Oyster Point Pharma to Attend the Piper Sandler 32nd Annual Virtual Healthcare ConferenceOyster Point Pharma to Attend the Piper Sandler 32nd Annual Virtual Healthcare Conference
finance.yahoo.com - November 25 at 9:15 AM
Oyster Point Pharma Announces Clinical Data Presentations on OC-01 Nasal Spray for Dry Eye Disease at the American Academy of Ophthalmology 2020 Virtual Annual MeetingOyster Point Pharma Announces Clinical Data Presentations on OC-01 Nasal Spray for Dry Eye Disease at the American Academy of Ophthalmology 2020 Virtual Annual Meeting
finance.yahoo.com - November 13 at 9:05 AM
Oyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q3 2020 Results - Earnings Call TranscriptOyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 7 at 11:22 PM
Oyster Point Pharma, Inc. (OYST) Q3 2020 Earnings Call TranscriptOyster Point Pharma, Inc. (OYST) Q3 2020 Earnings Call Transcript
finance.yahoo.com - November 6 at 12:57 PM
Oyster Point Pharma EPS beats by $0.11Oyster Point Pharma EPS beats by $0.11
seekingalpha.com - November 5 at 7:58 PM
Oyster Point Pharma Inc to Host Earnings CallOyster Point Pharma Inc to Host Earnings Call
finance.yahoo.com - November 5 at 2:58 PM
Oyster Point Pharma, Inc. (OYST)Oyster Point Pharma, Inc. (OYST)
finance.yahoo.com - November 1 at 2:04 PM
Oyster Point Pharma, Inc. Common Stock (OYST)Oyster Point Pharma, Inc. Common Stock (OYST)
nasdaq.com - October 29 at 6:20 PM
Oyster Point Pharma to Report Third Quarter 2020 Financial Results on November 5, 2020Oyster Point Pharma to Report Third Quarter 2020 Financial Results on November 5, 2020
finance.yahoo.com - October 29 at 6:20 PM
Oyster Point Pharma Announces Board of Directors Leadership Changes and New Appointment as the Company Advances into Next Phase of GrowthOyster Point Pharma Announces Board of Directors Leadership Changes and New Appointment as the Company Advances into Next Phase of Growth
markets.businessinsider.com - October 8 at 11:01 PM
Oyster Point Pharma to Present at the Morgan Stanley Virtual 18th Annual Global Healthcare ConferenceOyster Point Pharma to Present at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference
finance.yahoo.com - September 11 at 11:18 AM
Oyster Point Pharma IncOyster Point Pharma Inc
bloomberg.com - August 21 at 11:37 PM
Chief Commercial Officer John Snisarenko Just Bought 133% More Shares In Oyster Point Pharma, Inc. (NASDAQ:OYST)Chief Commercial Officer John Snisarenko Just Bought 133% More Shares In Oyster Point Pharma, Inc. (NASDAQ:OYST)
finance.yahoo.com - August 17 at 1:40 PM
Were Not Very Worried About Oyster Point Pharmas (NASDAQ:OYST) Cash Burn RateWe're Not Very Worried About Oyster Point Pharma's (NASDAQ:OYST) Cash Burn Rate
finance.yahoo.com - August 11 at 8:38 PM
We're Not Very Worried About Oyster Point Pharma's (NASDAQ:OYST) Cash Burn RateWe're Not Very Worried About Oyster Point Pharma's (NASDAQ:OYST) Cash Burn Rate
finance.yahoo.com - August 11 at 3:38 PM
Do Institutions Own Oyster Point Pharma, Inc. (NASDAQ:OYST) Shares?Do Institutions Own Oyster Point Pharma, Inc. (NASDAQ:OYST) Shares?
finance.yahoo.com - August 11 at 3:38 PM
Oyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q2 2020 Results - Earnings Call TranscriptOyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 8 at 12:00 AM
Oyster Point Pharma, Inc. (OYST) Q2 2020 Earnings Call TranscriptOyster Point Pharma, Inc. (OYST) Q2 2020 Earnings Call Transcript
fool.com - August 6 at 2:04 AM
Oyster Point Pharma Reports Second Quarter 2020 Financial Results and Recent Business HighlightsOyster Point Pharma Reports Second Quarter 2020 Financial Results and Recent Business Highlights
finance.yahoo.com - August 5 at 10:33 AM
Oyster Point Pharma to Report Second Quarter 2020 Financial Results on August 5, 2020Oyster Point Pharma to Report Second Quarter 2020 Financial Results on August 5, 2020
finance.yahoo.com - July 31 at 6:23 PM
Oyster Point Pharma Inc.Oyster Point Pharma Inc.
www.barrons.com - July 9 at 6:03 PM
Is Oyster Point Pharma, Inc. (OYST) A Good Stock To Buy?Is Oyster Point Pharma, Inc. (OYST) A Good Stock To Buy?
finance.yahoo.com - June 1 at 2:54 PM
How Oyster Point (OYST) Stock Stands Out in a Strong IndustryHow Oyster Point (OYST) Stock Stands Out in a Strong Industry
finance.yahoo.com - May 28 at 2:16 PM
Oyster Point Pharma Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional SharesOyster Point Pharma Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
www.marketwatch.com - May 20 at 4:10 PM
Oyster Point Pharma Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesOyster Point Pharma Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - May 19 at 7:08 PM
BRIEF-Oyster Point Pharma Announces Pricing Of Upsized Offering Of Common StockBRIEF-Oyster Point Pharma Announces Pricing Of Upsized Offering Of Common Stock
www.reuters.com - May 15 at 10:54 PM
Oyster Point Pharma Announces Pricing of an Upsized Offering of Common StockOyster Point Pharma Announces Pricing of an Upsized Offering of Common Stock
finance.yahoo.com - May 15 at 7:52 AM
BRIEF-Oyster Point Pharma Proposed Public Offering Of Common StockBRIEF-Oyster Point Pharma Proposed Public Offering Of Common Stock
www.reuters.com - May 12 at 11:12 PM
Oyster Point Pharma Proposed Public Offering of Common StockOyster Point Pharma Proposed Public Offering of Common Stock
finance.yahoo.com - May 12 at 6:11 PM
This page was last updated on 5/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.